Inhalable hybrid nanovaccines (NVRBD-MLipo) with virus-biomimetic structure against SARS-CoV-2 infection
Schematic illustration of inhalable hybrid nanovaccines (NVRBD-MLipo) with virus-biomimetic structure against SARS-CoV-2 infection. Nanovesicles are derived from genetically engineered 293T cell expressing RBD (NVRBD), which are further fused with pulmonary surfactant (PS)-biomimetic liposomes containing MPLA (MLipo) to yield NVRBD-MLipo. After inhalable vaccination, NVRBD-MLipo effectively enters alveolar macrophages (AMs) due to its PS-biomimetic property, and induces AMs activation through MPLA-activated TLR4/NF-κB signaling pathway. Furthermore, NVRBD-MLipo elicits T and B cells activation, as well as generates high level of RBD-specific IgG and secreted IgA (sIgA) with broad-spectrum neutralization activity against pseudoviruses, thus boosting protective mucosal immune and systemic immune responses
Publication
Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants (2024) Shuqi Wang, et al. J Nanobiotechnology. 2024;22(NA). Scheme: S1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | IgA | IGA | ncbigene_synonym | CD79A | 973 |
| Homo sapiens | Primates | CD80 | CD80 | ncbigene_symbol | CD80 | 941 |
| Homo sapiens | Primates | TLR4 | TLR4 | ncbigene_symbol | TLR4 | 7099 |
| Homo sapiens | Primates | TNF-&- | TNF | ncbigene_symbol | TNF | 7124 |
| Homo sapiens | Primates | CD86 | CD86 | ncbigene_symbol | CD86 | 942 |
| Homo sapiens | Primates | IL-12 | IL12 | famplex_relations | IL12A | 3592 |
| Homo sapiens | Primates | IL-12 | IL12 | famplex_relations | IL12B | 3593 |
| Homo sapiens | Primates | IL-6 | IL-6 | ncbigene_synonym | IL6 | 3569 |
| Homo sapiens | Primates | (P65) | P65 | ncbigene_synonym | RELA | 5970 |
| Homo sapiens | Primates | (P65) | P65 | ncbigene_synonym | SYT1 | 6857 |
| Homo sapiens | Primates | (P65) | P65 | ncbigene_synonym | GORASP1 | 64689 |
| Homo sapiens | Primates | (P65) | P65 | ncbigene_synonym | WNK1 | 65125 |
| Homo sapiens | Primates | NF-kB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | SP-D | SP-D | ncbigene_synonym | SFTPD | 6441 |
| Homo sapiens | Primates | SP-A | SP-A | ncbigene_synonym | CD5L | 922 |
| Homo sapiens | Primates | SP-A | SP-A | ncbigene_synonym | SFTPA1 | 653509 |
| Homo sapiens | Primates | SP-A | SP-A | ncbigene_synonym | SFTPA2 | 729238 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| DPPC | DPPC | (7R)-4-hydroxy-N,N,N-trimethyl-10-oxo-7-(hexadecanoyloxy)-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-oxide | chebi:40265 | |
| DPPG | DPPG | chebi:60358 | ||
| Nucleus | nucleus | nucleus | chebi:33252 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|